Heidi Health

Bottom line

Heidi Health is an ambient medical scribe built in Australia, now expanding into the US market, with native support for over 110 languages and a pricing model that starts with a functional free tier. For clinicians working in multilingual patient populations or international healthcare systems, Heidi offers broader language coverage than US-centric competitors like Nuance DAX or Abridge. The company positions itself as an EHR-agnostic solution with HIPAA and GDPR compliance, though integration depth varies by platform.

Pricing starts at $0 per month for a free tier with limited monthly transcriptions, then $99 per month for the Pro plan, and $199 per month for the Team plan with additional administrative controls. This sits at the mid-tier of the ambient scribe market, below premium enterprise solutions but above basic transcription-only services. Best fit: solo or small-group clinicians in multilingual markets (UK, Australia, Canada, US border regions, urban centers with diverse patient populations) who need flexible language switching without per-encounter charges.

The core limitation is evidence transparency. As of May 2026, Heidi has zero indexed PubMed citations and minimal clinician discussion on public forums like Reddit or Doximity. The vendor provides case studies and testimonials on its website, but independent validation is absent. Clinicians considering Heidi should plan for a trial period with fallback documentation workflows until performance is validated in their specific specialty and language mix.

Why we picked it

We selected Heidi Health as the best multilingual ambient scribe because it solves a problem that US-origin competitors largely ignore: patients who speak languages other than English. While Nuance DAX supports Spanish as a secondary feature and Abridge has announced multilingual roadmaps, Heidi launched with 110+ language models trained from the ground up. This includes not just European languages (Spanish, French, German, Italian, Portuguese) but also Mandarin, Cantonese, Hindi, Punjabi, Arabic, Vietnamese, Tagalog, and dozens of others. For a family medicine clinic in Toronto serving recent immigrants, or an urgent care center in Southern California with a majority Spanish-speaking patient base, this breadth is clinically relevant.

The Australian origin matters. Heidi was designed for the Australian public health system, where multilingual patient encounters are routine and EHR fragmentation is high. The company built EHR integrations that prioritize standards-based interoperability (FHIR, HL7) over vendor-specific APIs, which gives it flexibility in markets where Epic and Cerner do not dominate. This architectural choice means Heidi can integrate with regional EHRs common in the UK (EMIS, SystmOne), Australia (Best Practice, Medical Director), and Canada (OSCAR, Accuro) more easily than tools optimized solely for the US market.

The free tier is a meaningful differentiator. Most ambient scribes require upfront subscriptions or per-encounter fees that make trial evaluation expensive. Heidi offers 30 transcriptions per month at no cost, which allows a solo clinician to test the tool across multiple specialties and languages before committing to a paid plan. This lowers adoption friction for early-career physicians, locum tenens providers, and practices in under-resourced settings where budget approval cycles are slow.

The competitive set for multilingual ambient scribing is thin. Suki and DeepScribe focus on English-only workflows. Ambience Healthcare has announced multilingual support but deployment is limited to pilot sites. Nabla (France-origin) supports French and English but lacks the language breadth of Heidi. For clinicians who need production-ready multilingual transcription today rather than in a future roadmap, Heidi is the most deployable option as of mid-2026.

What it does well

Heidi captures ambient conversations in over 110 languages and generates structured clinical notes in the clinician's preferred output language, which can differ from the input language. A Spanish-speaking patient encounter can produce an English-language SOAP note, or vice versa. This cross-language transcription reduces cognitive load for bilingual clinicians who document in English but conduct visits in their patients' primary language. The tool uses speech-to-text models trained on medical terminology in each language, which reduces the error rate on drug names, anatomical terms, and specialty-specific jargon compared to general-purpose transcription engines like Google Speech-to-Text or Whisper.

The platform supports multiple output formats: SOAP notes, BIRP (Behavior, Intervention, Response, Plan), DAP (Data, Assessment, Plan), and custom templates. Clinicians can define field-level preferences (always include social history, suppress family history unless explicitly mentioned) and save these as reusable profiles. For specialists with repetitive documentation patterns (dermatology follow-ups, orthopedic post-op checks), this templating reduces the need for manual editing after each encounter. Output can be copied into an EHR via clipboard, sent via direct API integration where available, or exported as PDF or plain text for external systems.

Heidi includes a consent and privacy model designed for GDPR compliance, which exceeds HIPAA requirements in several areas. Patients can request deletion of their audio recordings within 30 days, and the system automatically purges raw audio after 90 days while retaining only the de-identified transcript. This is relevant for clinicians in the EU, UK, and Australia where patient data rights are more expansive than in the US. The vendor publishes a public-facing security page with SOC 2 Type II certification and penetration test summaries, which provides more transparency than many US-based competitors.

The mobile app allows clinicians to capture audio from a smartphone or tablet, which is useful for bedside rounds, home visits, telehealth calls, or any setting where desktop access is impractical. Audio is processed in real time or asynchronously depending on network quality, and the resulting note appears in the clinician's web dashboard within seconds to minutes. This flexibility is particularly valuable for hospitalists, palliative care teams, and rural clinicians who move between locations without consistent EHR access.

Where it falls short

EHR integration depth is inconsistent. While Heidi supports copy-paste into any EHR and offers FHIR-based API connections, deep bi-directional write integration (where the tool can push notes directly into discrete EHR fields and pull patient context to pre-populate templates) is available only for select platforms. Epic and Cerner integrations exist but are not universally deployed across all customer sites, and some users report needing IT intervention to enable API access due to institutional security policies. Clinicians at large health systems should expect a 4-to-8-week integration timeline and possible pushback from IT security teams unfamiliar with the vendor.

Specialty-specific optimization is unclear. The vendor does not publish performance benchmarks by specialty (cardiology vs dermatology vs psychiatry), and public case studies skew toward primary care and urgent care use cases. Specialists with high jargon density (oncology, rheumatology, interventional radiology) may find that the tool requires more post-editing than generalists, particularly in non-English languages where medical training corpora are smaller. The lack of published word-error-rate data by specialty and language makes it difficult to predict performance before trial deployment.

Customer references and clinician testimonials on the vendor website are anonymized or aggregated, with few named practices or quoted clinicians. This opacity is common in early-stage health IT vendors but makes independent verification difficult. Prospective buyers cannot easily contact peer institutions to validate deployment timelines, satisfaction, or ROI. The absence of case studies published in trade journals (Healthcare IT News, HIMSS) or peer-reviewed venues (JAMIA, Applied Clinical Informatics) suggests limited adoption at large academic medical centers or IDNs as of mid-2026.

The tool does not yet support real-time clinical decision support or ambient diagnosis suggestion, which differentiates it from next-generation competitors like Ambience Healthcare or Suki Assistant. Heidi transcribes and structures documentation but does not flag potential drug interactions, suggest ICD-10 codes based on documented symptoms, or surface relevant guidelines during the encounter. For clinicians seeking an all-in-one ambient assistant rather than a pure scribe, Heidi's scope is narrower.

Deployment realities

Initial setup takes 30 to 60 minutes per clinician: account creation, microphone configuration, consent workflow setup, template customization, and trial transcriptions to calibrate the model to the clinician's speech patterns and documentation style. The vendor provides onboarding videos and email support, but no live training sessions are included in the Pro plan. Team plan subscribers ($199/month) receive a dedicated account manager and group onboarding calls, which reduces time-to-productivity for practices with 3+ clinicians.

For practices seeking EHR integration beyond copy-paste, IT involvement is required. The clinician must request API credentials from their EHR vendor (if using Epic, this typically requires a MyChart or Interconnect agreement), then share those credentials with Heidi's support team to enable the integration. Some health systems block third-party API access by default, requiring a BAA (Business Associate Agreement) review and security questionnaire before IT will whitelist Heidi's servers. Budget 2 to 6 weeks for this process at mid-sized hospitals, longer at large IDNs with centralized IT governance.

Ongoing maintenance is low once deployed. The tool does not require software updates on the clinician's device (it is cloud-based), and model improvements are deployed server-side without user action. The main operational overhead is managing patient consent: clinicians must explain the tool's purpose at the start of each visit and document verbal or written consent per institutional policy. Some states (California, Illinois) require two-party consent for audio recording, which adds a step to the intake workflow. Practices should update their notice of privacy practices to disclose third-party transcription services.

Pricing realities

The free tier includes 30 transcriptions per month with full feature access, suitable for a solo clinician seeing 1 to 2 patients per day or a specialist using the tool only for complex visits. The Pro plan at $99 per month per clinician raises the cap to 300 transcriptions per month, adequate for 12 to 15 patient visits per day assuming some visits are too brief to warrant scribing (e.g., prescription refills, brief follow-ups). The Team plan at $199 per month per clinician adds unlimited transcriptions, role-based access controls, and centralized billing, which is relevant for group practices or departments where administrators need usage visibility.

Per-transcription overage fees apply if free-tier users exceed 30 encounters or Pro users exceed 300 encounters in a month. The vendor does not publish the overage rate publicly, which is a transparency gap. Prospective buyers should request this in writing during contract negotiation. For high-volume clinicians (20+ patients per day, 400+ per month), the Team plan with unlimited transcriptions becomes cost-effective compared to per-encounter fees charged by competitors like Abridge ($4 to $6 per encounter) or DeepScribe ($2.50 to $5 per encounter depending on volume).

Hidden costs include: EHR integration setup fees (varies by EHR, typically $500 to $2,000 as a one-time charge), additional user training beyond the included onboarding (billed hourly at rates not published), and premium support SLAs for enterprise customers (pricing available on request). The vendor requires annual contracts for Team plan subscribers, with early termination fees equivalent to 50 percent of remaining contract value. Month-to-month billing is available for free and Pro tiers, which reduces switching friction for individual clinicians.

Compliance + integration depth

Heidi Health is HIPAA compliant, with a signed BAA available to US customers upon request. The company holds SOC 2 Type II certification (most recent report dated Q4 2025) and is GDPR compliant, which is required for its UK and EU customer base. The vendor does not hold HITRUST certification as of May 2026, which may be a barrier for US health systems that mandate HITRUST for all third-party software. FDA clearance is not applicable because Heidi does not make diagnostic or treatment recommendations; it is a documentation tool only.

EHR integration is tiered. Basic integration (copy-paste from Heidi's web app into any EHR) works universally. API-based integration (FHIR or HL7) is available for Epic, Cerner, Athenahealth, eClinicalWorks, and several international EHRs (EMIS, SystmOne, Best Practice, Medical Director). Integration depth varies: some implementations support bi-directional write (Heidi can push notes into discrete EHR fields and pull patient demographics to pre-populate headers), while others are read-only or require manual triggering per encounter. Prospective buyers should request a technical integration guide specific to their EHR version before committing.

Heidi is not endorsed by specialty societies (American College of Physicians, American Academy of Family Physicians) or listed in the KLAS Emerging Solutions Spotlight as of mid-2026, which reflects its early stage and limited US market penetration. Australian and UK adoption is stronger, with mentions in primary care publications (Australian Doctor, Pulse UK) but no formal endorsements. Clinicians at institutions that require vendor validation through KLAS, ECRI, or peer academic medical center deployments will find limited precedent.

Vendor stability + roadmap

Heidi Health was founded in 2020 and is headquartered in Australia, with offices in the UK and a growing US presence. The company has raised venture funding (specific amounts and investors not publicly disclosed as of May 2026), which indicates runway beyond bootstrapped operations but does not guarantee long-term stability. The leadership team includes clinicians and health IT veterans from the Australian public health system, which informs the product's design priorities (multilingual support, EHR-agnostic architecture) but also means the company is newer to the US regulatory and payer environment.

Customer references on the vendor website are aggregated rather than named, with testimonials citing satisfaction but no attributed quotes from CMIOs, department chairs, or named practices. This lack of transparency is common for early-stage vendors but makes peer validation difficult. Prospective buyers should request contact information for 2 to 3 reference customers in similar specialties and geographies during the sales process. The vendor's LinkedIn presence shows steady hiring in engineering and customer success roles, which suggests growth rather than contraction.

The public roadmap (available on the vendor's blog) emphasizes deeper EHR integrations, expanded specialty-specific templates (cardiology, orthopedics, mental health), and real-time clinical decision support features planned for late 2026 and 2027. The company has stated interest in ambient diagnosis suggestion and ICD-10 autocoding, which would bring it closer to feature parity with Ambience Healthcare and Suki. However, these features are not yet in production, and timelines are subject to change. Buyers should evaluate Heidi based on current capabilities rather than roadmap promises.

How it compares

Nuance DAX (Dragon Ambient eXperience) is the market leader in US ambient scribing, with deep Epic integration, proven accuracy in English, and strong penetration at large academic medical centers. DAX supports Spanish as a secondary language but lacks the breadth of Heidi's 110+ language models. DAX pricing is higher (typically $150 to $300 per clinician per month depending on volume and contract terms) and requires annual enterprise agreements, which makes it less accessible for solo or small-group practices. Heidi wins on language diversity and pricing flexibility; DAX wins on US market maturity, Epic integration depth, and evidence base (multiple peer-reviewed studies, KLAS rankings).

Abridge is a US-based ambient scribe with strong investor backing (including CVS Health Ventures) and a focus on patient-facing summaries (patients receive a plain-language visit summary via email or app). Abridge supports English only as of mid-2026, with Spanish in pilot. Pricing is per-encounter ($4 to $6 per encounter) or per-clinician subscription ($120 to $180 per month), which can be more expensive than Heidi for high-volume users. Abridge wins on patient engagement features and US payer partnerships; Heidi wins on multilingual support and lower cost for high-volume clinicians on the Team plan.

Suki Assistant combines ambient scribing with real-time clinical decision support, suggesting ICD-10 codes, flagging potential drug interactions, and surfacing relevant guidelines during the visit. Suki supports English only, with Spanish announced for 2026. Pricing is $399 per month per clinician for the full assistant suite, or $199 per month for scribe-only mode. Suki wins on clinical intelligence features and venture-backed roadmap velocity; Heidi wins on multilingual support and lower entry price for scribe-only workflows. For clinicians who want transcription without clinical decision support, Heidi offers better value; for clinicians seeking an all-in-one ambient assistant, Suki is more feature-complete.

DeepScribe (now part of Abridge following a 2025 acquisition) focuses on specialty-specific scribing with models optimized for cardiology, orthopedics, and dermatology. DeepScribe supports English only and charges per-encounter fees ($2.50 to $5 depending on volume). DeepScribe wins on specialty optimization and per-encounter pricing transparency; Heidi wins on multilingual support and subscription-based pricing for predictable budgeting. For single-specialty practices with high English-only volume, DeepScribe's per-encounter model may be cost-effective; for multilingual or multi-specialty practices, Heidi's subscription model offers better economics.

What clinicians say

As of May 2026, Heidi Health has minimal visibility on US clinician forums. A search of Reddit's r/medicine, r/Residency, and r/physicians yielded zero mentions of Heidi in the prior 12 months. Doximity discussions similarly lack substantive threads on the tool. This absence of organic clinician conversation suggests limited US adoption or user-initiated discussion, which contrasts with competitors like Nuance DAX and Abridge that are frequently debated in these forums. Prospective buyers cannot rely on peer anecdotes to validate or contradict vendor claims.

The vendor's website includes testimonials citing improved documentation speed, reduced after-hours charting, and positive patient reactions to the ambient capture process. However, these testimonials are anonymized (no named clinicians or institutions) and lack quantitative detail (no time savings measured, no comparison to baseline). Independent validation of these claims is not yet available through third-party case studies, KLAS reports, or peer-reviewed publications. Clinicians considering Heidi should treat vendor testimonials as directional rather than definitive.

Australian and UK clinician feedback is slightly more visible. Mentions in Australian Doctor and Pulse UK cite ease of use and multilingual capability, but these are brief product spotlights rather than in-depth user reviews. The lack of long-form independent reviews in trade publications (Healthcare IT News, HIMSS Analytics) or clinician-authored blogs suggests the tool is still in early adopter phase outside its home markets. Prospective buyers should plan for a structured pilot period with internal evaluation metrics (time savings per encounter, post-editing burden, patient satisfaction) rather than relying on external validation.

What the literature says

As of May 2026, Heidi Health has zero indexed citations in PubMed. A search for 'Heidi Health' and 'ambient scribe' returned no peer-reviewed studies, pilot reports, or conference abstracts. This absence of academic validation is not unusual for a vendor founded in 2020, particularly one based outside the US where most health IT research is published. However, it means that prospective buyers have no independent evidence of clinical accuracy, time savings, or patient outcomes associated with the tool.

The broader ambient scribe literature provides context. Studies of Nuance DAX (JAMIA 2022, JAMA Network Open 2023) report 2 to 3 minutes of time savings per encounter and reduced after-hours documentation by 30 to 50 percent, with clinician satisfaction scores of 4.2 to 4.5 out of 5. Studies of Abridge (Health Affairs 2024) report similar time savings and note that patient-facing summaries improve recall of visit instructions. These benchmarks are useful for setting expectations, but they do not validate Heidi specifically, particularly for non-English languages where training corpora are smaller and error rates may differ.

The absence of published evidence is a material gap. CMIOs and clinical leaders evaluating ambient scribes for institutional deployment typically require peer-reviewed validation or at least independent case studies from peer institutions before approval. Heidi's lack of published data means that early adopters will need to generate their own evaluation data during pilot periods. This is feasible for small practices willing to measure time savings and documentation quality internally, but it is a barrier for risk-averse institutions or those with slow procurement cycles.

Who it's for

Heidi Health is best suited for solo or small-group clinicians in multilingual markets: urban primary care practices serving immigrant populations, border-region urgent care centers, Canadian family medicine clinics, UK NHS practices in diverse neighborhoods, and Australian GPs. These clinicians face frequent language switching and lack access to enterprise-grade multilingual scribes, making Heidi's broad language support and affordable pricing directly relevant. A family medicine physician in Toronto seeing patients in English, Mandarin, and Punjabi within the same day gains immediate value from Heidi's cross-language transcription that competitors cannot match.

The tool is also well-suited for early-career clinicians, locum tenens providers, and practices in under-resourced settings where budget constraints limit adoption of premium solutions like Nuance DAX. The free tier (30 transcriptions per month) allows trial evaluation without upfront cost, and the Pro plan at $99 per month is accessible on a resident or early-attending salary. For clinicians rotating through multiple sites or working part-time, the month-to-month billing and smartphone-based capture reduce adoption friction compared to enterprise contracts requiring institutional approval.

Heidi is less well-suited for large health systems or academic medical centers seeking deep EHR integration, specialty-specific optimization, and peer-validated evidence. IT leaders at Epic-dominant institutions will find more mature integrations with Nuance DAX or Suki. Specialists in high-jargon fields (oncology, interventional cardiology, rheumatology) may find that Heidi requires more post-editing than generalist workflows, particularly in non-English languages. CMIOs requiring HITRUST certification or KLAS validation will find neither as of mid-2026. These buyers should wait for additional evidence or plan for extended pilot periods with fallback documentation workflows.

The verdict

Heidi Health earns its designation as the best multilingual ambient scribe by solving a problem that US-origin competitors largely ignore: production-ready transcription in over 110 languages with cross-language output. For clinicians in multilingual markets, this capability is not a nice-to-have but a clinical necessity. The pricing model (free tier for evaluation, $99/month Pro, $199/month Team) is competitive, and the GDPR-compliant privacy architecture exceeds HIPAA baselines in several areas. The Australian origin and EHR-agnostic design make it more deployable in international markets and fragmented US settings where Epic and Cerner do not dominate.

The material weakness is evidence transparency. Zero PubMed citations, minimal clinician discussion on public forums, and anonymized vendor testimonials mean that prospective buyers cannot validate claims through peer references or published data. Specialty-specific performance is undocumented, EHR integration depth varies by platform, and the vendor lacks HITRUST certification or KLAS rankings. These gaps are typical of early-stage health IT vendors but impose adoption risk. Clinicians considering Heidi should plan for a structured pilot period (30 to 90 days, measuring time savings and post-editing burden) with a fallback documentation plan if performance does not meet expectations.

Decision rule: If you are a solo or small-group clinician in a multilingual market (urban Canada, US border regions, UK, Australia, or US cities with diverse patient populations), and you need ambient scribing that works across English, Spanish, Mandarin, French, German, or dozens of other languages, Heidi is the most deployable option as of mid-2026. If you are a CMIO at a large Epic-dominant health system, or a specialist requiring deep integration and peer-validated evidence, wait for additional data or pilot Nuance DAX or Suki instead. If you are an early-career clinician seeking to reduce documentation burden on a limited budget, the free tier makes Heidi a low-risk trial.